Intermittent high dose oral methotrexate therapy in psoriasis.
D000328:Adult; D000368:Aged; D001241:Aspirin / Q000009:adverse effects; D001259:Ataxia / Q000139:chemically induced; D003092:Colitis / Q000139:chemically induced; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D013262:Stevens-Johnson Syndrome / Q000209:etiology; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D001241:Aspirin; D008727:Methotrexate